Your browser is no longer supported. Please, upgrade your browser.
Forte Biosciences, Inc.
Index- P/E- EPS (ttm)-1.61 Insider Own26.54% Shs Outstand13.60M Perf Week-15.47%
Market Cap47.26M Forward P/E- EPS next Y-0.75 Insider Trans-21.82% Shs Float10.34M Perf Month-87.21%
Income-20.30M PEG- EPS next Q-0.36 Inst Own62.50% Short Float15.83% Perf Quarter-91.46%
Sales- P/S- EPS this Y84.30% Inst Trans10.30% Short Ratio0.89 Perf Half Y-87.02%
Book/sh3.67 P/B0.93 EPS next Y-21.60% ROA-41.90% Target Price- Perf Year-92.19%
Cash/sh- P/C- EPS next 5Y- ROE-44.10% 52W Range3.32 - 53.99 Perf YTD-90.62%
Dividend- P/FCF- EPS past 5Y19.50% ROI- 52W High-93.67% Beta0.41
Dividend %- Quick Ratio17.40 Sales past 5Y- Gross Margin- 52W Low2.86% ATR2.19
Employees10 Current Ratio17.40 Sales Q/Q- Oper. Margin- RSI (14)16.28 Volatility10.34% 9.39%
OptionableYes Debt/Eq0.00 EPS Q/Q95.50% Profit Margin- Rel Volume1.59 Prev Close3.49
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume1.83M Price3.41
Recom1.80 SMA20-81.43% SMA50-86.62% SMA200-89.50% Volume2,894,051 Change-2.15%
Sep-03-21Downgrade Truist Buy → Hold $4
Sep-03-21Downgrade Ladenburg Thalmann Buy → Neutral
Sep-03-21Downgrade Chardan Capital Markets Buy → Sell $105 → $4
Sep-03-21Downgrade B. Riley Securities Buy → Neutral $3
May-14-21Initiated B. Riley Securities Buy $73
Mar-26-21Initiated Citigroup Buy $75
Aug-28-20Upgrade Chardan Capital Markets Neutral → Buy $45
Aug-25-20Initiated Truist Buy $70
Sep-09-21 06:15PM  
Sep-08-21 08:51AM  
Sep-07-21 09:40PM  
Sep-06-21 12:42PM  
Sep-03-21 07:42PM  
Sep-02-21 04:05PM  
Aug-16-21 04:05PM  
Aug-02-21 04:01PM  
Jul-12-21 04:01PM  
Jul-07-21 10:02AM  
Jul-01-21 04:01PM  
May-14-21 03:06AM  
May-10-21 04:05PM  
May-03-21 04:30PM  
Mar-25-21 08:42AM  
Mar-24-21 08:00AM  
Mar-17-21 04:05PM  
Feb-23-21 04:01PM  
Feb-18-21 04:01PM  
Feb-13-21 03:18AM  
Feb-12-21 04:01PM  
Dec-02-20 11:26PM  
Nov-24-20 04:05PM  
Nov-16-20 04:05PM  
Nov-15-20 09:00AM  
Nov-10-20 04:05PM  
Nov-09-20 04:05PM  
Nov-02-20 04:30PM  
Oct-29-20 08:00AM  
Oct-28-20 04:09PM  
Oct-26-20 08:30AM  
Sep-29-20 09:00AM  
Sep-16-20 08:48AM  
Sep-09-20 04:01PM  
Aug-25-20 08:30AM  
Aug-10-20 04:00PM  
Aug-03-20 09:00AM  
Jul-28-20 08:30AM  
Jun-18-20 08:30AM  
Forte Biosciences Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing a live biotherapeutic FB-401 that has completed Phase 1/2a clinical trial to treat inflammatory skin diseases for pediatric atopic dermatitis patients. The company was incorporated in 2007 and is based in Torrance, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Riley Antony AChief Financial OfficerSep 07Sale4.2425,000106,10511,065Sep 07 04:09 PM
Wagner Paul A.See RemarksSep 07Sale4.351,000,0004,347,1001,279,049Sep 08 05:02 PM
DARCY THOMAS EDirectorJan 13Option Exercise9.595004,7932,358Jan 14 07:17 PM